The field of cancer research has increasingly focused on the metabolic underpinnings of tumorigenesis, recognizing how the reprogramming of cellular energy ...

In 2026, the spotlight will be on a handful of therapeutic strategies that could change cancer care for patients by offering ...

Lantern showcases two commercially ready, machine learning platforms that have the potential to accelerate drug discovery from months to days and dramatically reduce costs. predictBBB.ai and LBx-AI, ...

The U.S. Food and Drug Administration has granted Fast Track Designation to Oz-V for treating recurrent or metastatic squamous cell carcinoma of the head and neck. "We have a clear registrational path ...

The National Cancer Center Japan (NCC) has announced the start of a new clinical trial for an anticancer drug prescreened with tumor-bearing mice, saying the use of such mouse models could ...

This information is based on a press release statement from Celcuity. In other recent news, Celcuity Inc. has announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug ...

Many breast cancer drugs block estrogen receptors inside cancer cells. Blocking the receptors early in disease progression staves off metastasis. But most patients with advanced disease eventually ...

Advances in cancer research have led to an increasing number and variety of cancer therapies in the development pipeline, but there are concerns that traditional processes for drug development, ...

DelveInsight’s, “Gastric Cancer Pipeline Insight 2025” report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in Gastric Cancer pipeline landscape. It covers the Gastric ...

TOKYO -- Fujifilm Holdings has joined hands with German drugmaker Bayer to develop an immune-based cancer treatment using induced pluripotent stem cells.

Advances in cancer research have led to an increasing number and variety of cancer therapies in the development pipeline, but there are concerns that traditional processes for drug development, ...